Patent Grant
10166164
All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
Embodiments of the invention relate generally to systems and methods to provide compression therapy to a body part, and more specifically, to systems and methods to provide active and/or adaptive compression therapy to a body part.
Compression therapy (CT), is the selective external compression of a portion of the body using wraps, stockings, inflatable cuffs and bandages. CT can be either passive compression using elastic or inelastic bandages or multiple layers of bandages (no external energy applied) or active, where an external energy source augments a compressive force applied to body part(s), as shown in
Examples of the some of the commercially available compression bandages currently available include those made by 3M, BSN Medical, Convatec, Derma Sciences, Hartman group, Kendall/Covidien, Lohmann and Rauscher, Medline Industries, and Smith and Nephew. The compressive force of compression bandages is achieved in the application or wrapping of the bandage by a caregiver. The consistency of the compression is dependent on the skill of the caregiver applying the bandage. There is no feedback on the amount of compressive force applied with bandages. The patient is wears the bandage until the stocking loses its compliance or become soiled. Bandages are typically applied to the arms or legs.
Compression stockings (CS) are elastic stockings that are typically placed over the lower leg like long length sock or leg hosiery. The stockings are marketed to provide a specific level of compression, often greater compression at the ankle with reducing levels of compression toward the knee to compensate for the higher hydrostatic pressure toward the ankle when standing.
CS can be designed to provide a range of pressures to the lower leg. For example, a CS that delivers light compression can provide less than 20 mmHg of pressure; moderate compression is between 20 to 40 mmHg, strong compression between 40 and 60 mmHg and very strong compression can be over 60 mmHg.
Manufacturers offer a variety of compression levels up to 60 mmHg. Some manufacturers of CS include Bauerfeind, BSN, Kendell/Covidien, and Sigvaris.
Active compression (AC), often referred to as pneumatic compression devices use air chamber containing sleeves that enclose the patient's leg or foot. The three main categories of AC are foot pumps, that compress the venous sinus of the foot, intermittent pneumatic compression (IPC) that inflate and deflate the entire sleeve at the same time and sequential compression pumps (SC) that sequentially inflate chambers in the sleeve to move the blood (or milk) the blood toward the foot to enhance arterial flow, or toward the waist to improve venous, lymphatic fluid or enhance removal of lactic acid post-exercise.
AC devices are made in both plug-in and battery-powered mobile units as shown in
There is strong evidence that all these forms of compression therapy are helpful in treating or preventing the conditions for which they are used. The significant deficiencies that all of these technologies suffer from is unknown/inconsistent pressure application, poor comfort due to bulky, non-breathable cuffs and difficulty in donning/doffing the stockings or wraps. These design deficiencies result in non-compliance with the technologies, estimated to be as high as 70%. The root cause for poor compliance with compression therapy is multi-factorial. Standard tight fit stockings are hard to don/doff for someone who already has limited mobility due to their disease. Some clinicians resort to recommending that patients apply KY jelly over the leg to help don/doff the stocking, as well as using an external donning/doffing aid, such as a Jobst Stocking Donner (Model number 110913). In addition, although these stocking can be provided in multiple sizes, to the stockings often have problems with poor fit, including areas that are too tight causing pain or too loose causing the stocking to droop. Inelastic compression wraps (e.g. Unna boot) where the lower leg is wrapped in a series of layers of cotton wraps with zinc oxide and other compounds, are not well tolerated by patients either as they are rigid, uncomfortable, can develop a foul smell due to accumulation of exudates from the ulcer and must be changed weekly. Inelastic compression wraps have an additional burden as compression wraps must be changed often, which typically requires the patient to travel to a venous clinic and utilizes expensive nursing resources.
With millions of affected patients affected in the US and billions of dollars spent attempting to treat patients with poorly understood treatment regimens with devices that patients are reticent to use due to discomfort, there is clearly a need for a better technology. Therefore, there is a need for an innovative, multi-mode compression therapy system that addresses these problems.
The present invention relates generally to systems and methods to provide compression therapy to a body part, and more specifically, to systems and methods to provide active and/or adaptive compression therapy to a body part.
In some embodiments, a device for providing compression therapy to a body part of a patient is provided. The device may include a drive unit configured to be placed over or against a body part. The drive unit can include one or more motors; a controller configured to control operation of the one or more motors; a power source in electrical communication with the one or more motors and the controller; and a plurality of pulleys; one or more drive elements configured to be tensioned by the one or more motors, wherein the one or more drive elements are threaded around the plurality of pulleys; and one or more compression mechanisms configured to be wrapped at least partially around a portion of the body part, wherein the one or more compression mechanisms are attached to the pulleys and are configured to be tensioned by the pulleys.
In some embodiments, the plurality of pulleys comprises a plurality of movable pulleys and a plurality of fixed pulleys, and the compression mechanisms are attached to the movable pulleys.
In some embodiments, the device further includes one or more physical stops that limit the movement of the movable pulleys and are configured to align the movable pulleys.
In some embodiments, the drive element is selected from a cord, belt, and chain.
In some embodiments, the drive unit comprises a base plate that is articulated and comprises a first plate portion and a second plate portion.
In some embodiments, the one or more motors comprises a first motor disposed on the first plate portion and a second motor disposed on the second plate portion, and wherein the plurality of pulleys comprises a first set of fixed pulleys attached to the first plate portion and a second set of fixed pulleys attached to the second plate portion.
In some embodiments, the drive unit comprises a base plate and the fixed pulleys are disposed within one or more channels within the base plate.
In some embodiments, the movable pulleys are disposed within one or more channels in the base plate.
In some embodiments, the movable pulleys and the fixed pulleys are arranged within the one or more channels such that one or more drive cords extending between the movable pulleys and the fixed pulleys are aligned with a direction of travel of the movable pulleys within the one or more channels.
In some embodiments, the device further includes one or more sensors in communication with the controller, where the one or more sensors are configured to measure data related to the compression therapy provided to the patient and/or data related to the status of the patient.
In some embodiments, the one or more sensor includes a sensor configured to measure a magnitude of pressure applied to the body part by the device.
In some embodiments, the one or more sensors comprises a sensor configured to measure a girth or a volume of the body part.
In some embodiments, the device further includes a wireless communication module in communication with the controller.
In some embodiments, the one or more compression mechanisms are integrated into a garment or shoe.
In some embodiments, the drive unit is integrated into the garment or shoe.
In some embodiments, a method for compressing a body part of a patient is provided. The method includes fastening one or more compression elements of a wearable compression device around the body part. The wearable compression device may include a compression plate, one or more motors disposed on the compression plate and configured to tighten or loosen the one or more compression elements fastened around the body part, one or more sensors configured to measure physiological data and/or device performance data, and a controller for controlling the one or more motors according to a set of parameters. The method further includes adjusting a tension of the one or more compression elements until the one or more sensors measures a predetermined or set parameter before initiating compression therapy; initiating a first compression cycle comprising compressing the body part by using the one or more motors to tighten the one or more compression elements, and uncompressing the body part by using the one or more motors to loosen the one or more compression elements; waiting at least a predetermined or set amount of time before initiating a second compression cycle; measuring physiological data and/or device performance data using the one or more sensors; and modulating the treatment parameters based on the measured physiological data and/or device performance data.
In some embodiments, the predetermined or set parameter is an interface pressure between the compression device and the body part.
In some embodiments, the measured physiological data comprises a measurement of the girth of the body part or a volume of the body part.
In some embodiments, the method further includes delivering passive compression therapy by adjusting the pressure of the one or more compression elements to a predetermined level and maintaining the tension of the one or more compression elements at the predetermined level for an extended period of time that is at least about 1 minute to 24 hours.
In some embodiments, the method further includes wirelessly transmitting the measured physiological data and/or device performance data to a remote device.
In some embodiments, the method further includes establishing communications between the wearable compression device and a second wearable compression device; and coordinating delivery of compression therapy between the wearable compression device and the second wearable compression device.
In some embodiments, the one or more compression elements comprises at least two compression elements that are tightened sequentially.
In some embodiments, a device for compressing a body part is provided. The device may include a compression transmission mechanism having a first end portion and a second end portion, the compression transmission mechanism configured to be wrapped around at least a portion of the body part; a tightening mechanism configured to tighten and/or loosen the compression transmission mechanism; a first mechanical stop configured to provide a starting location for the first end portion of the compression transmission mechanism; a second mechanical stop configured to provide a starting location for the second end portion of the compression transmission mechanism; a sensor configured to measure a strain, force, or pressure applied to the body part by the system; a motor configured to tighten and/or loosen the compression transmission mechanism by simultaneously moving both the first end portion and the second end portion of the compression transmission mechanism; and a controller configured to provide an indicator when the sensor measures a set or predetermined strain, force, or pressure; and initiate compression treatment by actuating the motor after the strain gauge measures the set or predetermined strain, force, or pressure.
In some embodiments, the compression transmission mechanism comprises one or more compression straps.
In some embodiments, the compression transmission mechanism further comprises one or more pads for distributing pressure generated by the one or more compression straps.
In some embodiments, the compression transmission mechanism comprises one or more laces configured to be tightened by a reel based tensioning mechanism.
In some embodiments, a system for delivering compression therapy is provided. The system can include a first compression device comprising a compression plate, one or more motors disposed on the compression plate and configured to tighten or loosen one or more compression elements configured to be fastened around a first body part, one or more sensors configured to measure physiological data and/or device performance data, a communications module, and a controller for controlling the one or more motors according to a set of parameters; and a second compression device including a compression plate, one or more motors disposed on the compression plate and configured to tighten or loosen one or more compression elements configured to be fastened around a second body part, one or more sensors configured to measure physiological data and/or device performance data, a communications module, and a controller for controlling the one or more motors according to a set of parameters; wherein the first compression device and the second compression device are configured to communicate with each other and coordinate delivery of compression therapy.
In some embodiments, the first compression device includes a pulley based drive train that is driven by the one or more motors and configured to tighten or loosen the one or more compression elements.
In some embodiments, the pulley based drive train comprises a plurality of movable pulleys.
In some embodiments, the pulley based drive train further includes one or more physical stops that limit the movement of the movable pulleys and are configured to align the movable pulleys.
In some embodiments, a system for providing compression treatment to a subject is provided. The system may include a wearable compression device configured to provide compression to a body part of the subject, the wearable compression device comprising a compression plate, one or more motors disposed on the compression plate, one or more compression mechanisms configured to be wrapped around the body part and tightened or loosened by the one or more motors, one or more sensors configured to measure physiological data and/or device performance data, a controller for controlling the one or more motors according to a set of parameters, and a wireless communications module in communication with the controller and the one or more sensors; and a remote device configured to wirelessly communicate with the wireless communications module of the wearable compression device and to receive the measured physiological data and/or device performance data and to modulate the set of parameters for controlling the one or more motors.
In some embodiments, the system further includes a server or cloud computing network in communication with the remote device, the server or cloud computing network comprising a database that includes population health data, and personal health data, wherein the population health data comprises data from a population of subjects that used or are using compression treatment, wherein the personal health data comprises the subject's medical data, the subject's physiological data, and the device performance data, wherein the remote device, server or cloud computing network is configured to modulate the set of parameters for controlling the one or more motors based on the population health data and the personal health data.
In some embodiments, the remote device is selected from the group consisting of a smart phone, a smart watch, a tablet computer, a laptop computer, server, computing device, and a desktop computer.
In some embodiments, the remote device is programmed to wirelessly operate the wearable compression device.
In some embodiments, the remote device is programmed to wirelessly operate the wearable compressive device, alternating between an active compression mode and a passive compression mode.
In some embodiments, the remote device is programmed to wirelessly operate the wearable compression device according to one or more treatment protocols.
In some embodiments, the treatment protocols are predetermined.
In some embodiments, the treatment protocols are customizable by the subject and/or a healthcare provider.
In some embodiments, the controller and/or the remote device is programmed to modify one or more of the treatment protocols based on the measured physiological data and/or the device performance data.
In some embodiments, the controller and/or the remote device is programmed to select one of the treatment protocols based on the measured physiological data and/or the device performance data.
In some embodiments, the remote device is programmed to display the measured physiological data and/or the device performance data.
In some embodiments, the remote device is programmed to monitor subject compliance and display subject compliance data.
In some embodiments, the one or more sensors are selected from the group consisting of a strain gauge, a pressure sensor, a force sensor, a heart rate sensor, GPS device, a blood pressure sensor, microphone, Hall effect sensor, sweat biochemistry sensor, light sensor, an impedance sensor, a blood clot detection sensor, a blood flow sensor, an ultrasound sensor, a temperature sensor, a gas sensor, a blood chemistry sensor, a physical activity sensor, oxygen sensor, EKG sensor, gyroscope, and an accelerometer.
In some embodiments, the measured physiological data includes plethysmography data.
In some embodiments, the controller and/or the remote device is programmed to determine a disease state and/or treatment efficacy based in part from the plethysmography data.
In some embodiments, the controller and/or the remote device is programmed to modify one or more of the treatment protocols based on the plethysmography data.
In some embodiments, the remote device is programmed to prompt the subject for treatment related data.
In some embodiments, the remote device is programmed to send the subject reminders regarding the compression treatment and/or compliance with the compression treatment.
In some embodiments, the remote device is programmed to send updates regarding the compression treatment and/or the subject to healthcare providers, family members, and/or other authorized individuals.
In some embodiments, the remote device is configured to upload the measured physiological data and/or device performance data to the server or cloud computing network.
In some embodiments, a system for providing compression treatment to a subject is provided. The system may include a wearable compression device configured to provide compression to a body part of the subject according to a set of treatment parameters, the wearable compression device including a plurality of sensors configured to measure a level of compression applied to the body part and to measure physiological data and/or device performance data, memory to record the level of compression applied to the body part, a controller for controlling the compression delivered by the wearable compression device, and a wireless communications module in communication with the controller; a remote device configured to wirelessly communicate with the wireless communications module of the wearable compression device and to receive the measured physiological data and/or device performance data and to modulate the set of treatment parameters for controlling the wearable compression device; and a server or cloud computing network in communication with the remote device, the server or cloud computing network including a database that includes population health data, and personal health data, wherein the population health data comprises data from a population of subjects that used or are using compression treatment, wherein the personal health data includes the subject's medical data, the subject's physiological data, and the device performance data, wherein the remote device, server or cloud computing network is configured to modulate the set of parameters for controlling the compression device based on the population health data and the personal health data.
In some embodiments, the plurality sensors are configured to measure physiological data selected from the group consisting of the subject's body part girth, body part volume, posture, physical activity level, venous filling time, venous reflux, venous index, ulcer status, heart rate, oxygen level, temperature, blood pressure, sweat biochemistry, impedance, temperature, oxygen level, electrical activity, and blood flow dynamics.
In some embodiments, the set of treatment parameters for controlling the compression device includes compression level, compression duration, compression frequency, and compression speed.
In some embodiments, the compression device further includes a pulley based drivetrain that is driven by one or more motors.
In some embodiments, the set of parameters for controlling the compression device are modified based on artificial intelligence or machine learning algorithms.
In some embodiments, the remote device, server, or cloud computing network is programmed to monitor the subject's compliance with the compression treatment.
In some embodiments, the remote device, server, or cloud computing network is programmed to send reminders to the subject to initiate compression treatment.
In some embodiments, the remote device, server, or cloud computing network is configured to generate status updates regarding the subject's compression treatment that can be viewed by the subject and other authorized individuals.
In some embodiments, a device for delivering compression therapy to a subject is provided. The device may include a wearable compression mechanism configured to compress a body part of the subject; one or more sensors configured to measure physiological data of the subject and/or performance data of the wearable compression mechanism; and a controller configured to control the wearable compression mechanism based on a set of compression parameters; and modulate the set of compression parameters using machine learning and/or artificial intelligence algorithms based on the measured physiological data and/or performance data.
In some embodiments, a device for delivering compression therapy to a subject is provided. The device may include a wearable compression mechanism configured to compress a body part of the subject; a sensor configured to measure an interface pressure between the wearable compression mechanism and the body part; and a controller configured to control the wearable compression mechanism based on a set of compression parameters; and initiate compression of the body part and/or modulate the set of compression parameters based on the measured interface pressure.
The novel features of the invention are set forth with particularity in the claims that follow. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:
Described herein are systems, devices, and methods that make compression therapy comfortable, consistent, easy to use, and customized to increase compliance with a proven therapy. In addition, the use of an effective, low profile, mechanical drive system in combination with modern sensing, data management and remote interface enables the system to add functionality that will improve outcomes. The basis of the system is the mechanical tensioning and coordination of therapy among multiple compression bands around a part of the body. The system is further enabled by sensors, mechanical feedback, and user input that enable real-time monitoring, adjustments and adaptation to the individual patients' anatomy, physiology, tolerance, and therapeutic needs. Finally, the unique data steams form this device including mechanical, physiological, imaging, and patient feedback data can be leveraged on both an individual and population basis with analytics and artificial intelligence in order to optimize therapy for both individuals and populations.
Described herein are systems, devices, and methods that enable both standard compression and active therapy in a mobile, lightweight, breathable, simple interface that encourages compliance with remote monitoring capability. Additional features of strain gauge plethysmography, tilt sensing, compliance and remote monitoring are included to facilitate better outcomes through accumulation of a large database of treatment outcomes. Various embodiments include a “smart” stocking that can use real time data and proprietary algorithms in order to implement customized treatment that learns and adapts to the specific patient needs and disease state progression.
In some embodiments, as shown in
Alternative drive drains that may be pulley-less include using twisted pairs of drive cords that are attached on one end to the compression strap or mechanism, as described in U.S. Patent Publication No. 2008/0066574, for example. The other end of the twisted pair actuator can be attached to a motor that can twist the pair of drive cords to shorten the twisted pair and generate force and compression, and the motor can untwist the twisted pair to lengthen the twisted pair to reduce the force and compression. Yet another pulley-less drive train can include directly attaching the drive cord to the compression strap or mechanism and omitting the pulleys.
For example, the system can include the parts and features listed below in Table 1.
In summary, a motor turns a drive shaft with a drive pulley. The drive pulley spools a drive cord threaded through a pulley based drivetrain, which includes both compression plate pulleys that are fixed on a compression plate and movable compression strap pulleys that transmit force from the motor to a compression strap system. Tension is applied to the compression straps as the drive pulley spools the drive cord, and tension is released by reversing the motor and the rotation of the drive shaft and the attached drive pulley, thereby allowing the drive cord to unspool. In addition, the compressed leg or other body part naturally provides a reactive force that promotes unspooling and unloading.
The system will now be described in more detail. As shown in
The compression plate/active compression assembly can be indexed, aligned and positioned properly on and around the stocking by aligning the compression plate/active compression assembly with index markers or patterns on the compression stocking and/or attachment to a compression stocking attachment that is integrated on the stocking. As shown in
The active components of the system can index or zero itself to establish a reliable and consistent baseline configuration before initiating active compression therapy, as shown in
The compression straps of the system, as shown in
As shown in
The pad 602 and backing component 604 can be a molded EVA foam or plastic that fits over the front portion of the lower leg. Use of the pad and backing component may allow the compressive force to be more evenly transmitted to the body part than using discrete compression straps alone, which may improve patient comfort. The backing component can be sized and shaped to cover the portions of the leg that are adjacent or proximate the lace of the closure system in order to ensure that the lace does not transmit force directly against the patient's skin. If compression straps are used, the backing component 604 can include compression strap guides 620, such as loops, for attaching and aligning the backing component with the rest of the device, as shown in
Other embodiments can utilize an alternative closure system as shown in
The compression components that include the compression plate, motors, pulley system, controller, battery, and drive cord can also be disposed on a pad 602, which can be made of foam or other comfortable material as described above for the backing component 602. The compression component can be removably attached to the pad which allows the pad to be changed when needed, such as when the pad is soiled or the leg girth changes.
Other closure systems can use different tensioning mechanisms. For example,
Although the descriptions herein generally discuss the use of compression straps, any of the closure systems described herein can be used instead
In some embodiments, active feedback is provided via wearable sensor(s) (e.g., pressure, force and/or strain sensors) and a feedback system to index the pressure or tension applied by the compression straps and/or compression plate to a prescribed baseline condition or value. For example, the motor can be driven to rotate the drive pulley until a sensor in line with the drive cord reads a desired strain, or a sensor against the patient's skin or against the compression stocking measures a desired pressure, or a sensor measures that the motor draws a predetermined or a set current which can be correlated to a load on the motor, which can be correlated to strain.
Sensors can be integrated into the stocking, the backing component (e.g., the foam cuff), compression straps, the drive cord, the lace(s) for fastening mechanism, the tensioning reel of the fastening mechanism, the motor, and/or the force/pressure transmission components.
The system may be capable of providing user/patient feedback prior to active compression engagement to ensure that baseline conditions are achieved before beginning active compression therapy. For example, the system may be capable of verbally (e.g., in plain spoken language of recorded caregiver), auditory (beeps or other), or visually (on-board display, smartphone or remote control) providing a cue to engage the user/patient to reset device to baseline conditions. User feedback (e.g., auditory, visual, tactile) can be provided to the user when baseline compression level is achieved. In addition, user feedback (e.g., auditory, visual, tactile) can be provided to notify the user/patient that baseline compression level has not yet been reached.
In some embodiments, the drive pulley rotation is engaged for specific time interval, number of rotations, and/or power output (e.g. input drive function), per prescribed parameters, which may be predetermined or selected at the beginning or during treatment. In addition or alternatively, the input drive functions can be modulated by as sensor measurements (e.g., stain gauge, accelerometer), in order to deliver a precise and consistent amount of compression to the user/patient. For example, an integrated strain gauge, pressure sensor, and/or force sensor can be provided to provide real time feedback of compression level in the mechanical compression system so that the system can provide a predetermined, set, or desired level of compression, such as light compression less than 20 mmHg of pressure, moderate compression between 20 to 40 mmHg, strong compression between 40 and 60 mmHg or very strong compression over 60 mmHg. The pressure sensor, force sensor, or strain gauge can be positioned against the skin or against the stocking and under the base plate, compression straps, compression mechanism, pads, and/or backing to measure the interface pressure, which is the actual pressure applied to the body part, in contrast to an inflatable compression device that may only report the inflation pressure.
Integrated strain gauge plethysmography on the wearable treatment system can be used to adjust therapy system with real time feedback. The sensors can be placed on a skin facing surface, such as the back of the compression plate as shown in
The drive cord may be spooled and unspooled around a drive pulley that is fixed to the drive shaft of the motor. As the motor rotates the drive shaft and drive pulley, the spooling or unspooling of the drive cord generates or releases tension in the drive cord that is translated to individual or multiple compression straps through a pulley system that includes fixed pulleys attached to the compression plate and movable pulleys attached to the compression straps. The pulley system can provide a mechanical advantage greater or less than 1:1 depending on the pulley configuration used. For example, attaching two movable pulleys to a compression strap will generally increase the mechanical advantage to greater than 1:1, so long as the drive cord generating the force on the compression strap is oriented generally parallel to the direction of the generated force, while reducing the amount of travel of the moveable pulleys attached to the compression strap.
In addition, gearing can be used to obtain greater or less than a 1:1 gear ratio from the output of the drive motor, which also allows for the generation of mechanical advantage to increase the compressive force that can be achieved with a given motor.
In order the reduce tangle of the drive cord around the drive pulley, rotation and spooling of the drive cord around the drive pulley can be limited to about 360 degrees or less (i.e., about one rotation or less) of the drive pulley. The size and circumference of the drive pulley therefore can determine the amount of travel or spooling of the drive cord, which along with the pulley system configuration, determines the amount of compression applied by the compression straps. The size of the pulley can be chosen to have the smallest circumference that provides the desired amount of drive cord travel to generate the desired amount of compression. This would result in the smallest tangle free drive pulley, which allows the system to have a reduced, slimmer, more compact form factor.
The use of cams, different pulley sizes, different numbers of pulleys, allows for variation of mechanical advantage in specific zones, or remote adjustment of zone (e.g. use greater mechanical advantage, longer travel, drive cord with less elasticity to deliver more compression to lower leg zones). For example, the use of a cam allows the mechanical advantage to be varied during a compression cycle to better approximate native muscle contraction and/or to alter compression dynamics. One or more movable pulleys can be attached to each end of the compression strap in order to equalize and/or balance the forces applied to the compression strap. If a movable pulley is attached to only one end of the compression strap while the other end of the compression strap is, for example, fixed in place, then the generated force may tend to torque and twist the leg, which may be uncomfortable to the user, in addition to creating the desired compressive force. By balancing the forces with pulleys attached to both ends, the torqueing and twisting force is eliminated or reduced while still providing the compressive force. Similarly, a pulley based attachment system, as shown in
As shown in
The compression plate 316 shown in
A cover 740, as shown in
Active feedback from strain gauges can be used to evaluate efficacy of treatment and adjust treatment independent of user input for compression therapy system. The compression system may be capable of providing a compression cycle frequency of greater than 1 Hz, although in some embodiments, the system is also capable of providing a much lower cycle frequency, so as 1 compression and release about every 1 to 60 seconds, or about every 5, 10, 15, 20, 25, or 30 seconds, in order for blood to refill the veins between compressions. The speed of compression allows the system and method to achieve native or healthy flow rates, volumes, and flow dynamics curves, and can be tailored to match the needs of each patient and disease state. The speed and timing of the compressions of the individual compression zones allows the system to generate specific venous, arterial, or lymphatic flow waveforms that cannot be achieved using an inflatable cuff. The compression system may be capable of generating compressive forces greater than about 60 mmHg and in some embodiments, in excess of 200 mmHg. In some embodiments, the compression system may be capable of generating compressive forces between about 0 and 60, 70, 80, 90, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, or 200 mmHg. The compression system may be capable of providing a circumferential stroke length of greater than about 0.5 in per compression zone, or greater than about 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, or 1.0 inch per compression zone. The circumferential stroke length is the reduction in circumference of the system, i.e. the compression straps and compression plate wrapped around the body part, and body part during a compression cycle. In some embodiments, the compression system is capable of delivering zone specific treatment, meaning each compression zone can independently deliver a prescribed amount of compression at a prescribed cycle frequency.
The compression zones can be generated using a variety of techniques. For example,
As shown in
For example, a unit placed on the lower leg may deliver a compression to the lower leg, and then a unit on the upper leg can deliver a compression to the upper leg after a set delay in order to drive blood through the venous vasculature. These modular features allow a set of smaller devices to be combined into a larger device that can still provide coordinated compression between each of the compression zones in the combined system. In addition, the units can have different sizes to fit the different body parts, such as the lower leg, the upper leg, the lower arm, the upper arm, the hand, the fingers, and the torso, for example. The units can come in multiple predetermined or customized sizes that fit various ranges of body part circumferences, such as extra small, small, medium, large, and extra large. Although the units may be synchronized, the one or more units may be operated independently and be operated at its own compression level and frequency.
Connected Health, Precision Medicine, Smart Medicine
The compression systems and methods described herein include gathering position data (e.g., compression strap/pad position, patient position—standing or laying down or sitting, device position), pressure/compression data, temperature data and/or other relevant parameters and data from the sensors of the mobile/wearable compression therapy system. The data may be transmitted wirelessly or through a wired connection to a smart phone, smart watch, tablet, laptop computer, desktop computer, other computing device or other receiving device.
For example, integrated, wireless strain gauge plethysmography can be performed using a strain gauge to measure the change in the circumference and volume of the body part, which allows the determination of the volume of blood being pumped. Other techniques can also be used to determine the circumference and/or volume of the treated body part. For example, the drive cord position (i.e. how much of the drive cord is wound up) can be determined by using, for example, a Hall Effect sensor to monitor the rotation of the drive pulley and/or drive shaft. The current draw or load on the motor can also be correlated with drive cord position, and both the current draw and the drive cord position can be correlated with the compression pressure delivered to the body by the system. The compression strap or other closure mechanism position can be similarly determined (i.e. using a Hall Effect sensor or other sensor on the tightening mechanism or monitoring current of the motor if a motor is used to drive the tightening mechanism). Alternatively or additionally, the closure system, such as the compression straps, can have visual indicators or markings indicating the circumference of the body part.
Strain gauge plethysmography or other forms of plethysmography can also be used to determine blood flow hemodynamics, such as blood flow velocity and heart rate. See “Beat-by-beat forearm blood flow with Doppler ultrasound and strain-gauge plethysmography”, M. E. Tschakovsky, J. K. Shoemaker, R. L. Hughson, Journal of Applied Physiology, September 1995, 79 (3) 713-719. Other physiological measurements that can be determined include nitric oxide levels, which is a vasodilator and can be determined by using strain gauge plethysmography. See “New Methods to Evaluate Endothelial Function: Method for Assessing Endothelial Function in Humans Using a Strain-Gauge Plethysmography: Nitric Oxide-Dependent and -Independent Vasodilation”, Yukihito Higashi and Masao Yoshizumi, J Pharmacol Sci 93, 399-404 (2003).
Plethysmography can also be used to measure the venous volume and to calculate a venous filling index (VFI). Changes in leg volume can be measured using the compression device around the calf to deliver a pre-set compression pressure with the patient in a supine position. The limb being evaluated can then be elevated to drain the venous system. Once the venous system is emptied, the leg volume is determined by the system and recorded and the patient is asked to stand, after which the change in volume is determined and recorded again. The difference in the recorded leg volume is the functional venous volume. The time needed to fill 90 percent of the functional venous volume is the venous filling time. The venous filling index is functional venous volume divided by the venous filling time; a normal venous filling index is <2 mL/sec. The greater the venous filling index, the more severe the reflux. The residual volume fraction, which is the ratio of the residual volume to the function venous volume, is directly proportional to ambulatory venous pressure, which is used to diagnose venous hypertension. Each one of the parameters, the leg volume, the functional venous volume, the venous filling time, the venous filling index, and the changes of these parameters over time as the treatment progresses, can be used by the treatment algorithm to optimize compression treatment parameters. For example, if an adjustment of compression parameters results in an indication that the patient's condition is worsening, such as an increasing venous filling index, the treatment parameters can be reverted back to the previous treatment conditions and/or further modulated.
In addition, measurement of the circumference and volume of the treated body part may be correlated to healing progression for certain diseases, since as the body part heals, the swelling tends to be reduced, resulting in a decrease in circumference and volume for the treated body part. Data from the sensors can be transmitted and analyzed, using the processors on the compression system itself and/or using remote processing from a smart phone, smart watch, tablet, other computing device, server, or cloud computing network, and compression treatment can be adjusted based upon the data.
For example, an accelerometer or gyro can be used to determine body position, such as when the patient is lying down or standing up. Since there is often a significant difference in diameter and circumference of a swollen leg between the standing and lying down positions, the system can adjust the baseline compression pressure by tightening or loosening the drive cord or the closure mechanism when it detects a change in posture. The system may also include a delay before adjusting the baseline pressure to accommodate the lag or delay between a change in posture and a resulting change in the diameter/circumference of the body part, and to avoid changing the baseline pressure for a short duration change in posture.
The system can analyze personal health data that is collected and recorded from the patient, such as data in the patient's electronic health record and the data collected by the sensors during treatment, which includes compression treatment parameters such as compression/pressure magnitude, duration, and frequency along with patient compliance, and compare and correlate the compression treatment parameters and dosing with healing response and disease state outcomes or progression which can be monitored by the system as described herein. Treatment parameters and dosing can be modulated, and healing response and disease state outcomes can be monitored to determine whether the modulated parameters resulted in improved outcomes or healing response (e.g., reduced body part circumference, diameter, and/or volume).
In addition, the system can access population health data that is compiled from a variety of sources, such as medical studies, hospital data, and data recorded from a population of patients using the systems and devices described herein or other compression devices. The population health data can include data regarding the treatment given to the patient, the treatment outcome, healing progress, patient compliance, and demographic data such as the patient's age, race, sex, and other medical conditions. The system can analyze the population health data to find the treatments that resulted in the best outcomes in patients that have a similar background or demographic and can modulate the current treatment parameters based on those treatments.
The system can also access reference data, such as geolocation, income, and weather.
The data analysis can be performed by a variety of computing devices, such as on a smart phone, tablet, laptop computer, or desktop computer that is maintained by the patient. In some embodiments, the patient controlled computing devices can analyze patient health data and use such data to modulate treatment parameters. Analysis of data can also be done on remote computing devices, such as servers or cloud computing networks, which may be better suited to perform data analysis of population health data in addition to analysis of personal health data. In some embodiments, patient controlled devices may analyze both personal health data and population health data.
Important data streams that can be sensed, monitored and/or recorded by one or more sensors on the device or independent of the device and used to by the treatment algorithm to modulate treatment include compression pressure delivered to the patient, blood pressure, compression dose (i.e. compression level/magnitude, compression duration, frequency, dwell time, treatment duration), patient's position (standing versus lying down), leg girth, activity level, venous filling time, venous volume, venous reflux, venous index, ulcer status, heart rate, oxygen level (measured using pulse oximeter for example), temperature, auditory cues such as snoring, blood flow, and ischemia. For example, oxygen levels in the lower leg and/or foot can be correlated to the ability to pump blood
The mobile/wearable compression system and method can incorporate artificial intelligence, fuzzy logic, machine learning and/or other decision algorithms for determining and/or adjusting the treatment parameters based on feedback from the sensor data and analysis and comparison with personal health data and/or population health data. An onboard microprocessor system can be programmed to “learn” and adjust therapy based upon the integrated sensor data stream. The mobile/wearable compression therapy system is capable of monitoring compliance with the prescribed treatment algorithm by, for example, logging usage of the device and comparing it to the prescribed treatment regimen. An interactive compression therapy system can be provided that is capable of asking patient questions via graphical and text user interface and/or audio questions and prompts. The compression therapy system may adjust, adapt, and/or modulate treatment based upon user input or analyses of user input. For example, the patient may indicate that the treatment is not working well, and the system may then initiate a more aggressive treatment schedule by increasing the magnitude of the compression and/or the frequency of compression, and/or the duration of compression (i.e., increasing the compression dosing). The patient may input data, submit/upload pictures and/or input other information related to treatment. The data can be used to refine treatment based upon that data.
The compression therapy system, and/or a computing device, server, or cloud computing network associated with or part of the compression therapy system, may send patients reminders via text, phone, and/or email regarding their treatment or compliance with their treatment. The compression therapy system, and/or a computing device, server, or cloud computing network associated with or part of the compression therapy system, may be programmed to send caregivers, family or loved ones updates on therapy via text, phone and/or email. The compression therapy system may upload treatment data from the compression device on a prescribed schedule, such as at the end of a prescribed treatment, or at regular intervals during treatment, such as about every 1, 2, 3, 4, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 90, 120, 150, or 180 minutes, or at prescribed times of the day, such as once a day at 8 pm, for example. In some embodiments, the data may be uploaded continuously or in real-time during treatment. The system and method can use real time data and/or stored historical data acquired from a population of patients using compression therapy to adjust the treatment of some or all of those patients.
The system may have remote control capability for controlling the compression therapy system that allow a caregiver or other authorized person to be able to change the treatment algorithm and/or parameters remotely. For example, remote control may include operating the compression device using a smart phone, tablet, or other computing device. These remote control devices may be paired directly with the compression device, and/or may communicate wirelessly or through a wired connection with a device that has already been paired with the compression device, such as a smart phone that has been paired with the compression device. Authorized persons other than the patient, such as an authorized health care provider, may control or modulate administration of treatment and may review recorded data to verify treatment compliance. For example, a physician may modulate the treatment prescription based upon compliance, ulcer healing progression, and data from strain gauge plethysmography, which may be used to measure the circumference and volume of the treated body part which can be correlated to healing progression since as the body part heals, the swelling tends to be reduced, resulting in a decrease in circumference and volume.
The compression therapy system may “reward” patients for treatment compliance with positive reinforcement via verbal, text or email, for example. The system may also tabulate patient compliance and generate credits redeemable for gifts, prizes, or discounts or rebates that can be applied to medical fees and/or insurance fees such as copays and/or deductibles, for complying with a physician directed course of treatment. The system may provide the patient with automated reminders and instructions for using the system. The compliance data may be accessed by the patient and/or health care provider. Notifications can be provided to the patient and/or health care provider when the patient is out of compliance (i.e., missed a scheduled treatment).
The system can include a social network component. For example, the system can provide updates to social networking sites regarding the status of the treatment and the treatment compliance of the patient. A social hub can be created for patients that are using the treatment to discuss their treatment and to provide support. In addition, the social hub can create a competition or leaderboard that rewards patients that meet treatment compliance levels.
The compression therapy system may be capable of modulating between a “passive” mode at specific set point and “active” mode at specific compression function. In the “passive” mode the compression therapy system can act similarly to a passive compression stocking to deliver a static amount of compression to the body part, except that the pressure or tension delivered by the compression system can be specified and maintained, even in the body part changes size as the result of posture and time, such as caused in the leg by standing upright versus laying down for sleeping, which can be detected using an accelerometer or gyro, for example. Light compression can provide less than 20 mmHg of pressure; moderate compression is between 20 to 40 mmHg, strong compression between 40 and 60 mmHg and very strong compression can be over 60 mmHg. The “active mode” has been described herein and provides active, cyclical compression of the body part according to prescribed treatment parameters, such as compression pressure magnitude, duration, and frequency, and overall treatment duration. Active compression can be provided while the patient is awake during specified times and/or upon initiation by the patient, while passive compression can be provided between active compression treatments, while the patient is asleep, and/or upon initiation by the patient.
Monitoring systems capable of notifying caregiver/manufacturer remotely of system malfunctions and/or need to replace components, and to automatically order and send those components to the patient/caregiver, can be integrated into the compression therapy system. The system may be capable of “learning” patient habits and adjusting treatment for convenience, comfort or efficacy of treatment based upon real-time and/or historic capture of diagnostic information.
For example, the system can identify wake and sleep patterns and activity patterns for the patient and can initiate treatments, such as active compression when the patient is awake, and passive treatment when the patient is asleep, or activate treatment when the patient is typically active and standing. The system can also identify what times compression treatments are most effective, as measured by reduction in leg girth or volume for example, as prioritize or direct compression treatment to those times.
The basic principle of operation of one embodiment is: two custom modified battery-powered brushless servo motors drive a single drive cord that is routed over a plurality of pulleys to sequentially pull and release one to six compression straps per motor. Two motors define lower calf and upper calf regions, activated sequentially to obtain natural, sequential compression from the lower to upper calf. The control unit, including electronic control systems and battery can be detached from the stocking, leaving the compression straps at a pre-defined compression level in a lightweight stocking mode.
The prototype electronic system is powered by a Raspberry Pi® zero that can support multi-client web access and local storage capability. The Raspberry Pi component can be replaced with a custom ASIC that incorporates all the needed components of the Raspberry Pi. Running the controller is a version 3.2Arduinio® platform, which can be replaced with custom ASIC and/or software. Voltage, current, Hall Effect, wifi and/or Bluetooth, force sensitive resistor (FSR) and tilt sensors allow efficient power control, positional sensing of bands, patient posture monitoring, and remote control and monitoring.
The proposed instructions for use for one embodiment are:
1) microfiber breathable soft stocking is pulled over leg, by for example, first releasing the front drawstring (running over pulley system to make release and tensioning easy), 2) pull compression device over stocking on lower leg, soft handles help user hold in place while positioning the device on alignment marking on the stocking, 3) tighten attachment system of compression device until movable pulleys are positioned against the physical stops and optionally until the compression device indicates appropriate pre-tension is achieved through an indicator, which can be auditory or visual 4) activate pre-tension routine on smart-phone to achieve appropriate set-point 5) active/passive compression routine activated, 6) release button and pre-tension released, 7) attachment system can be released and stocking removed. For cleaning, the motor drive module can be removed and stocking washed in washing machine.
Utilizing tension band positional, strain, current draw and pressure data, the device can incorporate strain gauge plethysmography capability, where the volume changes of the limb in response to applied pressure facilitate venous disease diagnosis. This would be very useful as it can be used to actively monitor progression of treatment and adjust if needed. Caregiver could remotely monitor real-time treatment progress and compliance. Ideally, this allows the clinicians to remotely make changes and schedule patients for visits based upon objective treatment data. This would reduce the burden on providers and facilitate better outcomes for this significant population of patients. This system also has significant market potential beyond venous ulcer treatment as it can be optimized for other conditions in which IPC is proven but compliance is low including DVT prophylaxis, lymphedema and peripheral arterial disease.
Current embodiments of the Radial system can achieve up to about 90 cm/s venous blood flow velocity in the veins in the legs. Pneumatic systems cannot achieve these venous blood flow velocities because of the long time it takes to fill the gas bladders, typically about 1 to 3 minutes, whereas the Radial system can deliver full compressions at a frequency of up to 1 Hz or more, such as up to 2, 3, 4, 5, 6, 7, 8, 9, and 10 Hz. Initial testing using the smart phone interface and remote wifi or Bluetooth control of the system has been successful with pre-tensioning, cycling and release modes achieved. Initial testing has demonstrated successful proof of concept that the Radial Medical SVS system is capable of delivering uniform and clinically meaningful pressures with fully functional remote control and monitoring.
Other Applications of System
In addition to the above described embodiments, various alternative compression device embodiments may be provided in a number of different configurations to address a wide variety of external medical, internal medical, industrial and athletic applications and use cases. It is to be appreciated that the compression devices, form factor, design envelope, drive systems, operations, methods and techniques described herein may be scaled, modified, adapted or otherwise suitably configured to use these various controlled power compression mechanisms and techniques to meet the following various different exemplary use cases and applications in these and similar configurations, uses or treatment of similar disease states or patient classifications. Still further, the compression devices may be configured for operation in active mode, power driven mode, passive mode or combinations of various modes depending upon the application and desired performance of the compression device or devices if more are working in concert.
Venous Duplex Ultrasound Examination
Venous duplex ultrasound is used for the diagnosis, evaluation, and management of many venous diseases, including chronic venous disease of the lower limbs, lower extremity venous insufficiency, and most other venous disorders. The duplex ultrasound includes (1) real-time B-mode ultrasound imaging that can generate images of the blood vessels and other soft tissues, and (2) pulsed Doppler ultrasound to determine blood flow characteristics, such as velocity, direction and laminar or turbulent flow. A linear 5-7 Mhz ultrasound transducer can be used for imaging and Doppler.
The examination typically involves performing both the imaging and Doppler measurements while compressing the area under examination every 2 cm or less. Typical veins that are examined include the proximal common femoral vein (bilateral examination), the sapheno-femoral junction, the mid femoral vein, the great saphenous vein, the popliteal vein, sapheno-popliteal junction, and the small saphenous vein. Other veins that may be examined include the inferior vena cava, common iliac, external iliac, proximal deep femoral, gastrocnemius, soleal, and perforating veins. Compression of the body part is typically done using manual compression delivered by the health care professional's hands. However, manual compression suffers from practitioner to practitioner variability, compression to compression variability for a single practitioner, and practitioner fatigue. This variability reduces the utility and/or accuracy of the examination, making it more difficult to compare the results with standard guidelines. In addition, it is desirable to achieve a high peak venous velocity during the examination. Instead of manual compression, a cuff inflator is sometimes used in order to provide more reliable, controlled and consistent amount of compression. However, such cuff inflators typically take longer to reach adequate compression than manual compression, which results in longer times to complete the examination, particularly because numerous compressions are often needed to cover the area under examination. In addition, cuff inflators cannot achieve high peak venous velocities due to the relatively long fill times.
Therefore, it would be desirable to provide a system and method for providing rapid, controlled, and consistent compression to specific areas of a body part while performing duplex ultrasound.
The compression systems and devices described herein can be used to provide rapid, controlled, and consistent compression of the body part for venous duplex ultrasound examination. In one embodiment, the compression device can include one compression strap and one motor that delivers rapid compression at a predetermined or set pressure. The compression can reach the predetermined or set pressure in less than 1, 2, 3, 4, or 5 seconds. The duplex ultrasound system can be positioned downstream of the compression device. The compression system can be manually actuated, using a foot pedal, a remote control device, or a smart phone, hand held device, button, or switch for example, which may also trigger the duplex ultrasound system to take a recording. Alternatively, the duplex ultrasound system may be actuated by the foot pedal, remote control device, smart phone, hand held device, button, or switch, which then also may trigger the compression system after an optional delay. Once the recordings are taken, the compression device and duplex ultrasound system can be repositioned for the next measurement. In some embodiments, the compression system can include an ultrasound transducer to perform the duplex ultrasound examination. The ultrasound transducer can be placed on the compression plate or on an independent strap that can be fastened at or downstream of the area being compressed.
In another embodiment, the compression device can be modified to provide multiple zones of compression that can be spaced apart 2 cm or less. Each zone of compression can include a compression strap with a thickness of 2 cm or less that can be independently driven by a motor, which can be a dedicated motor for the compression strap. A separate duplex ultrasound system can be used to take the imaging and Doppler recordings, or one or more ultrasound transducers can be integrated into the compression device, such as the compression plate or straps, or provided as an additional component that can be inserted under the compression plate and/or under/above the compression straps and/or positioned on a downstream portion of the body part. For example, one ultrasound transducer can be provided for each compression zone. Once the system is triggered to start as described above for the single compression zone embodiment, the multi-zone system can actuate each zone by itself in a sequential manner to automatically perform the duplex examination over the entire body part that is covered by the device. This reduces the amount of repositioning that is required to completely examine the target area and reduces the examination time.
Exemplary Additional External Use Medical Applications—Device Configured for External Use
Compression Device Configured for Chest Compression Assistance
In still other alternative configurations, one or more or a combination of the compression devices or methods of operation of one or more compression devices described herein may be scaled in size, modified, or adapted to be suitably configured to provide compression to the ribs and chest area. In one aspect, such a compression device may find utility as a chest compression device such as one used for CPR. In other configurations, the sequence, rate and delivered degree of compression force may be adjusted for use in combination with compression devices working alone or in combination to provide massage therapy, lymphedema therapy, sports or activity related recovery therapy or other therapy described herein.
The CPR compression devices described and illustrated in
Compression Device Configured for Forearm Compression Assistance
In still other alternative configurations, one or more or a combination of the compression devices or methods of operation of one or more compression devices described herein may be scaled in size, modified, or adapted to be suitably configured to provide compression to the forearm area.
In this illustrative embodiment of the compression devices in
Compression Device Configured for Finger Compression Assistance
In still other alternative configurations, one or more or a combination of the compression devices or methods of operation of one or more compression devices described herein may be scaled in size, modified, or adapted to be suitably configured to provide compression to one or more portions of a finger or a thumb.
Compression Device Configured to Provide Smart Tourniquet Functionality
In still other alternative configurations, one or more or a combination of the compression devices or methods of operation of one or more compression devices described herein may be scaled in size, modified, or adapted to be suitably configured to provide compression to an affected portion of the body where a desired treatment is the use of a tourniquet. In one illustrative embodiment, a limb such as a leg has been lacerated resulting in damage to one or more arteries or other blood vessels. The compression device is configured to be positioned on the limb over the affected vessel and then operated to apply pressure sufficient to act as a tourniquet. The compression device may be used directly on the limb, in combination with absorptive material such as gauze or a wound dressing.
Smart Wound Patch for Compression Therapy
In still other configurations, the compression device is used with a specifically designed wound dressing sensor patch. Embodiments of a wound dressing sensor patch include one or more sensors with one or more layers of material.
In other compression device smart tourniquet configurations, the sequence, rate and delivered degree of compression force may be adjusted for use in combination with sensor inputs or data collected or measured by the compression device or in communication with the compression device related to the health of the patient wearing the compression device, the affected limb or an extremity of the affected limb. In the case where the affected limb is a leg, an extremity would be the foot or the toes. In the case where the affected limb is an arm, an extremity would be the hand or fingers. Examples of information related to the health of the patient or the affected limb include any measure or indicia of vascular health or damage, neurological health or damage including, for example, EKG, EEG, EMG, degree of perfusion, pulse oximetry measurements, blood flow information or other suitable information whether obtained by observation or collected by instrument. In one aspect, a sensor used to measure or provide an indicia of vascular health or damage, neurological health or damage of the patient or affected limb is provided to the compression device controller. In one specific aspect, the sensor is one for the detection of the amount of or rate of bleeding at the affected site. In one aspect an absorbent pad positioned between the compression device and the laceration is used to curtail blood flow. In alternative configurations of the compression device or smart patch, additional healing conditions are introduced to the affected limb such as introduction of oxygen, light or other wound therapy adjuncts provided by one or both of the compression device or smart patch. In other aspects, one or more sensors within or associated with the measurement of the conditions in the pad related to one or more of flow of blood or rate of flow of blood or time since no new blood flow detected may be used as a feedback loop to aid in reduction or adjustment of the compression level applied to the affected limb by the compression device. The compression device controller includes computer readable instructions for alerting a user or adjusting compression level automatically or to a pre-determined level based on a sensor reading. Additionally or optionally, the tourniquet configured compression device may reduce the compression level periodically or at a predetermined time period or on demand so as to provide for vascular circulation and perfusion of the affected limb. In one aspect, a tourniquet configured compression device includes simple controls to increase compression on the limb until bleeding stops. Once bleeding is observed to stop, the compression device holds that level of compression. If bleeding resumes, the level of compression may be increased again until the bleeding is stopped at which time the compression device holds the new higher compression level. In one aspect, the compression device includes a release button, command or functionality to be used when the tourniquet function is no longer required and the compression device releases the pressure applied to the affected limb. In another aspect, the compression device includes an adjust pressure button, command or functionality to be used when the tourniquet compression level is reduced slightly to permit circulation to the affected limb particularly to the extremity of the affected limb. The adjust pressure function may be activated on demand or at a periodicity selected to reduce or minimize risk of damage the affected limb or extremity.
In the illustrative embodiments of
Compression Device Configured for Adaptive Fit Control for Prosthesis
In still other alternative configurations, one or more or a combination of the compression devices or methods of operation of one or more compression devices described herein may be scaled in size, modified, or adapted to be suitably configured to provide compression to an amputated limb sufficient to secure or assist in securing a prosthetic device to the stump of the amputated limb.
In one aspect, there are one or more compression devices provided on the device to be positioned along the stump to provide for massage or stimulation therapy. In another alternative aspect, one or more compression devices are configured to hold the prosthetic device in position against the stump. As a result of the controllable and configurable nature of the various embodiments of a compression device, the stump may be provided with compression therapy without compromise to the stability and positioning of the prosthesis to the stump. In one specific configuration, one compression device is configured to provide a hold force on a portion of the prosthesis to be maintained adjacent to the stump and two or more compression devices are provided to the portion of the stump adjacent to the prosthesis connection point. In another aspect, one or more compression devices or different segments of a single compression device are operated to perform two different functions. One portion of the compression device operates to hold the prosthetic in place relative to the stump. The compression device may be outfitted with a receptacle configured to receive and then apply hold force to a corresponding component on the prosthetic. In another portion of the compression device, there is provide variable and controllable hold force to aid in maintaining the prosthetic in position relative to the stump such as by maintaining the position of a strap or harness. In addition or optionally, the portion of the compression device engaged with the patient's stump may also provide constant, variable, graduated or massaging compression forces to the stump portion coupled to the compression device. The operation of this portion of the compression device may be responsive to a user's comfort, activity level, a subjective determination of the user or an objective treatment recommendation such as massage or release at timed intervals based on time of day or activity. In various other aspects, the compression device may be configured with a display, a touch screen display, control buttons, sensors or other accessories as described herein as suited to the adaptation of the compression device to this use category. As described herein, the operational characteristics of the compression device configured for use with a prosthesis may be controlled or monitored remotely using a smart phone, handheld device or other suitable mode of communication.
Compression Device Configured for Operation on Patient with Inoperable Peripheral Arterial Disease
In still other alternative configurations, one or more or a combination of the compression devices or methods of operation of one or more compression devices described herein may be scaled in size, modified, or adapted to be suitably configured to provide compression therapy to a patient with inoperable peripheral arterial disease. In these configurations, the operation of the compression device is commonly adapted to address two clinical burdens common to these patient populations, namely, limb ischemia and risk of amputation along with systemic vascular dysfunction and involvement of other vascular beds that pertains to cardiovascular complications, such as myocardial infarction and stroke. In one aspect, there are one or more compression devices are configured for use by a patient with an inoperable condition wherein the compression devices are adapted and configured for foot/calf compression, calf/thigh compression, foot/calf/thigh compression in any configuration in support of a compression regime suited to the disease state of the patient. In one aspect, the sequencing of the compression devices is used in or out of sequence with the heart cycle to assist in moving oxygenated blood out to the lower limbs and extremities. In still further aspects, compression devices and operating parameters may be adapted for advantageous use by patients having one of more of infrainguinal bypass grafting, local vascular dysfunction, lower extremity angioplasty and systemic dysfunction. The compression device based therapy may be intermittent, sequential, graduated or sequenced to provide a desired benefit to the patient receiving therapy. In one aspect, compression cycle of the compression devices produces a pressure of more than 100 mm Hg, 110 mm Hg or 120 mmHg or other pressure level as programmed into the compression device controller. During relaxation cycles the compression device can be operated to provide any level of pressure below that provided during the compression cycle to as low as 0 mm Hg or only sufficient pressure to maintain the compression device in position on the patient. While desiring not to be bound by theory, it is believed that compression devices as described herein and configured for these patient classes may provide clinical results and performance comparable or superior to those achieved by intermittent compression provided by pneumatic compression devices. In one aspect of this or other configurations of a compression device, one or more pressure sensors or other devices used to measure systolic/diastolic pressure is provided in the compression device along with controller instructions to monitor blood pressure and adjust compression levels to enable blood pressure measurements. In still other aspects, embodiments of the compression devices described herein may similarly deliver important clinical implications in grafted limbs when an increase in graft flow is required: (a) prevention of graft failures in low-output cardiac conditions; (b) contraindication to anticoagulation, and (c) during the peripheral vascular readjustment in late postoperative phase that often results in an increase in peripheral resistance. As a result, embodiments of the compression devices described herein are believed to provide an alternative to but equally conservative method for lower limb blood flow augmentation. As a result, the various alternative configurations and operational characteristics of compression device embodiments so configured to delivery intermittent compression of the lower limb may be a reliable, noninvasive therapeutic option, ameliorating claudication and assisting infrainguinal bypass graft flow. Additional features, characteristics and operational parameters of compression devices configured for these patient categories may be appreciated with reference to the following: “The Treatment of Peripheral Arterial Disease with Mechanical Compression and Angioplasty with Focus on Vascular Dysfunction;” Husmann, Marc (2016, Mar. 2). “The Treatment of Peripheral Arterial Disease with Mechanical Compression and Angioplasty with Focus . . . ” Retrieved from www.researchgate.net/publication/281726960; Delis, Konstantinos T. et al. Effects of intermittent pneumatic compression of the calf and thigh on arterial calf inflow: A study of normal, claudicants, and grafted arteriopths. Accepted for publication Jul. 10, 2000; Surgery 2001; 129:188-95; Delis, Konstantinos T. et al. Haemodynamic effect of intermittent pneumatic compression of the leg after infrainguinal arterial bypass grafting. British Journal of Surgery 2004; 91: 429-434; Husmann, Marc et al. Integrity of venoarteriolar reflex determines level of microvascular skin flow enhancement with intermittent pneumatic compression. Journal of Vascular Surgery December 2008: Volume 48, Number 6: 1509-1513; Husmann, Marc et al. Long-term effects of endovascular angioplasty on orthostatic vasocutaneous autoregulation in patients with peripheral athereosclerosis. Journal for Vascular Surgery November 2006: Volume 44. Number 5: 993-997; Husmann, Marc et al. Successful lower extremity angioplasty improves brachial artery flow-mediated dilation in patients with peripheral arterial disease. Journal for Vascular Surgery November 2008: Volume 48, Number 5: 1211-1216, each of which is incorporated herein by reference in its entirety.
Compression Device Configured for Operation on a Patient Having Obstructive Sleep Apnea
In still other alternative configurations, one or more or a combination of the compression devices or methods of operation of one or more compression devices described herein may be scaled in size, modified, or adapted to be suitably configured to provide compression therapy to a patient having obstructive sleep apnea. In one aspect, there are one or more compression devices along the legs of the patient configured to operate while the patient sleeps. In one aspect, the operation of the compression devices is configured to be responsive to the patient respiration cycle, the patient sleep cycle, the patient's use or operation of a breath assistance device alone or in any combination. In one illustrative example, a compression device system arranged for this use is configured to operate on an auditory signal of patient's breathing such as snoring or other breath signature recognized by the compression device controller or on a signal received from a breath assistance device such as a CPAP or similar respiration assistance device. In another aspect, the patient with sleep apnea wears a compression device that provides intermittent, constant, timed or other desired compression therapy during the day prior to the retiring to sleep when no compression therapy is applied. In another aspect, the compression device is operated to provide an active compression therapy benefit comparable to the benefit provided by a patient wearing a passive compression device with a 20 mm Hg applied pressure for a duration of 10-12 hours. In one aspect, the compression device is operated for one to four hours prior during the patient waking hours with the compression device removed during sleep. Additional other operational characteristics and possible benefits for compression devices configured for this patient class are described in “Attenuation of Obstructive Sleep Apnea by Compression Stockings in Subjects with Venous Insufficiency,” by S. Redolfi, et al, Am J Respir Crit Med Vol 184, pp. 1062-1066, 2011, the entirety of which is incorporated herein by reference.
Compression Device Configured for Operation on a Hospitalized Patient to Prevent Deep Vein Thrombosis (DVT)
In still other alternative configurations, one or more or a combination of the compression devices or methods of operation of one or more compression devices described herein may be scaled in size, modified, or adapted to be suitably configured to provide compression therapy to a hospitalized patient with deep vein thrombosis. In one aspect, there are one or more compression devices positioned along the legs of the patient to provide for massage or stimulation therapy to aid in the treatment or alleviation of symptoms of deep vein thrombosis.
In one embodiment, the compression device worn by the patient is in communication with other patient based sensors and may adapt compression therapy in response to patient data from in room sensor or information, in addition or optionally, in response to sensors provided with and operation in cooperation with the compression device. In some embodiments, the compression device may be modified to have a wired or wireless connection to the hospital network or in-room sensors. Additionally or optionally, the compression device may be modified to provide data on settings, use, duration, compression dose or other compression therapy parameters to an electronic medical record. In still other configurations, the compression device may be configured to provide or operate with available sensors such as an ultrasound sensor, strain gauge or other sensor used to detect an indicia of patient vascular health.
Compression Device Configured for Use to Provide Region Specific Massage to a Patient with Lymphedema.
In still other alternative configurations, one or more or a combination of the compression devices or methods of operation of one or more compression devices described herein may be scaled in size, modified, or adapted to be suitably configured to provide compression therapy to treat or alleviate systems related to lymphedema.
In one configuration, one or more compression devices may be worn by a patient to orient the compression in alignment with the patient's lymph nodes or other site of swelling identified for compression therapy. Alternative embodiments include the use of the one or more compression devices with or without an undergarment including attachment of the compression devices on, in or within a garment to facilitate donning and doffing the compression devices in the affected area of the patient anatomy.
The compression device or combination of compression devices for a particular limb are applied to the associated region of the body or regions of the body in any combination. Thereafter, each of the compression devices is activated in a predetermined sequence which applies controllable, repeatable pressure to the muscles, vasculature and lymphatic system in any desired sequence depending upon desired clinical results or patient specific needs such as localized swelling of a body part or limb. In one aspect, the one or more compression devices is activated in a serial compression mode. The serial compression mode of controllable compression therapy acts on the associated muscles and veins to mimic the action of walking. As a result of serial compression mode operation, blood is moved through the veins towards the heart so as to prevent pooling of blood in the lower limbs.
Still further, configurations of one or more controllable compression devices may be used to create gradient compression on the leg muscles and veins to provide a massaging effect which imitates the natural flow of lymph from the distal end of the limb (foot) toward the trunk of the body, mimicking the action of leg movement, such as walking, to move blood and fluids through the veins towards the heart. It is to be appreciated that the one or more controllable compression devices may be adapted and configured to vary the amount of compression, rate of the application of compression, hold time for compression, release time/rate of compression for each compression device operating alone or in conjunction with one or more other controllable compression devices as described herein. In one aspect, the one or more compression devices are applied to the patient and then sequentially operated to provide a gradient of pressure in the leg or any limb by adjusting the compression profile of each of the controllable compression devices. In one exemplary embodiment there is provided appropriate operational parameters of the one or more compression devices from ankle to knee (or mid-thigh) to a pressure of 45-50 mmHg at the ankle, 35 mmHg at the calf, and 30 mmHg at the thigh. Other pressure gradients are possible. Moreover, the duty cycle of the compression cycle includes a compression period and a relaxation period. In one embodiment, the compression cycle is 10 seconds, 15 seconds, 20 seconds with a relaxation cycle of from 60 seconds or more between successive compression cycles. In some embodiments, the compression cycle is timed to operate in sequence with all or a portion of the patient's heartbeat.
Exemplary configurations include, for example, (a) compression devices worn on both legs and operated in sequence to provide compression therapy to a portion of the lymphatic system in the legs; (b) compression devices worn on both legs configured with a support garment in the form of pants and operated in sequence to provide compression therapy to a portion of the lymphatic system in the legs; (c) compression devices worn on one or both arms and the chest and operated in sequence to provide compression therapy to a portion of the lymphatic system in the arms and the chest; (d) compression devices worn on worn on one or both arms and the chest and operated in sequence to provide compression therapy to a portion of the lymphatic system in the arms and the chest configured with a support garment in the form of a jacket; (e) compression devices worn on one or both arms and operated in sequence to provide compression therapy to a portion of the lymphatic system in the arms; (f) compression devices worn on worn on one or both arms and operated in sequence to provide compression therapy to a portion of the lymphatic system in the arms and configured with a support garment in the form of jacket sleeves as shown in
Compression Device Configured for Sports or Activity Related Recovery
In still other alternative configurations, one or more or a combination of the compression devices or methods of operation of one or more compression devices described herein may be scaled in size, modified, or adapted to be suitably configured to provide compression therapy to aid in sport preparation, sport training or recovery after activity specific, sports or athletic exertion. In these various embodiments, the compressive forces delivered by the one or more compression devices is aligned with muscle groups, joints or soft tissue to provide massage to affected areas alone or in combination with other affected regions as a result of the completed activity. In some configurations, one or more compression devices are adapted for use in blood flow restriction (BFR) training.
In one aspect, the one or more compression devices provided for this purpose are oriented and grouped according to the degree and manner of compression therapy suited to the desired outcome such as lactic acid removal, fluid removal, swelling, muscle fatigue and the like. As a result, the compression device or groups of devices are aligned to provide compression therapy or massage to affected areas. The compression devices may be placed on the affected area directly or incorporated on, in or within a suitable garment with a form factor appropriate to ease of donning and doffing while retaining the compression device in position for a particular therapy session. Exemplary garment form factors include, by way of example, a total body coverall, a jump suit, a pair of pants, a pair of shorts, a jacket, one or set of sleeves, gloves, boots, shoes, stockings, socks or a wrap. Exemplary compression devices are illustrated on, in or within a sleeve of jacket (see
The compression device or combination of compression devices for a particular limb are applied to the associated region of the body or regions of the body in any combination in relation to the therapy sought in relation to the completed activity, sport or athletic event. Thereafter, each of the compression devices is activated in a predetermined sequence which applies controllable, repeatable pressure to the muscles, vasculature and soft tissues including the lymphatic system in any desired sequence depending upon desired clinical results or patient specific needs such as pain, discomfort, localized swelling of a body part or limb. In one aspect, the one or more compression devices is activated in a serial compression mode. The serial compression mode of controllable compression therapy acts on the associated muscles and veins to mimic the action of walking. As a result of serial compression mode operation, blood is moved through the veins towards the heart so as to prevent pooling of blood in the lower limbs. Additionally or optionally, the mode of operation of one or more compression devices may be to move fluids away from the heart or to provide compression at levels associated with massage—ranging from gentle to firm to deep tissue, based on degree of compression applied.
Still further, configurations of one or more controllable compression devices may be used to create gradient compression on the limbs to provide a massaging effect to imitate natural fluid flows toward or away from the core, or toward or away from an extremity as desired in a particular therapy. It is to be appreciated that the one or more controllable compression devices may be adapted and configured to vary the amount of compression, rate of the application of compression, hold time for compression, release time/rate of compression for each compression device operating alone or in conjunction with one or more other controllable compression devices as described herein. In one aspect, the one or more compression devices are applied to the patient and then sequentially operated to provide a gradient of pressure in the leg or any limb by adjusting the compression profile of each of the controllable compression devices. Moreover, the duty cycle of the compression cycle includes a compression period and a relaxation period. In one embodiment, the compression cycle is 10 seconds, 15 seconds, 20 seconds with a relaxation cycle of from 60 seconds or more between successive compression cycles. In some embodiments, the compression cycle is timed to operate in sequence with all or a portion of the patient's heartbeat.
Exemplary activity, sports and athletic recovery configurations include, for example, (a) compression devices worn on both legs and operated in sequence to provide compression therapy to a portion of the muscles, joints, soft tissue or lymphatic system in the legs; (b) compression devices worn on both legs configured with a support garment in the form of pants and operated in sequence to provide compression therapy to the muscles, joints, soft tissue or lymphatic system in the legs; (c) compression devices worn on one or both arms and the chest and operated in sequence to provide compression therapy to the muscles, joints, soft tissue or lymphatic system in the arms and the chest; (d) compression devices worn on worn on one or both arms and the chest and operated in sequence to provide compression therapy to the muscles, joints, soft tissue or lymphatic system in the arms and the chest configured with a support garment in the form of a jacket; (e) compression devices worn on one or both arms and operated in sequence to provide compression therapy to the muscles, joints, soft tissue or lymphatic system in the arms; (f) compression devices worn on worn on one or both arms and operated in sequence to provide compression therapy to the muscles, joints, soft tissue or lymphatic system in the arms and configured with a support garment in the form of jacket sleeves; (g) compression devices worn on one or both hands and operated in sequence to provide compression therapy to muscles, joints or soft tissue of the hands or fingers; and (h) compression devices worn on one or both hands and operated in sequence to provide compression therapy to muscles, joints or soft tissue of the hands or fingers and configured with a support garment in the form of gloves or mittens.
Exemplary Additional Internal Use Medical Applications—Device is Configured for Internal/Implantable Use
Compression Device for Use as a Smart Gastric Banding Device
In still other alternative configurations, one or more or a combination of the compression devices or methods of operation of one or more compression devices described herein may be scaled in size, modified, or adapted to be suitably configured for implantation into the body on or about a portion of the stomach or other portion of the gut to treat or alleviate bariatric disorders.
Dynamically controlled gastric occlusion device 16 includes an occluding device 12, such as a compression device configured as a gastric band, and appropriate control circuitry 18 for controlling compression device operation to produce the desired degree of gastric constriction, and thus the size of the stoma opening from the stomach, provided by gastric occluding device 12. In the case of a gastric band, decreasing the inner diameter of the gastric band increases the degree of gastric constriction provided by the band. At least one sensor, such as sensor 14A and/or 14B, monitors a physiological parameter that varies as a function of food intake. An implanted control module 20 monitors and analyzes the sensed physiological parameters and dynamically controls adjustment of the gastric band 12 based on time or based on the monitored physiological parameter. When the physiological parameter so indicates, control module 20 generates and transmits an adjustment control signal to control circuitry 18 within occluding device 12. Control circuitry 18 receives the adjustment control signal and adjusts occluding device 12 accordingly. Additional details for the use and operation of a compression device for this purpose may be obtain from United States Patent Application Publication US 2006/0173238 entitled, “Dynamically Controlled Gastric Occlusion Device,” which is incorporated here in its entirety.
Compression Device for Cardiac Reinforcement or Treatment
In still other alternative configurations, one or more or a combination of the compression devices or methods of operation of one or more compression devices described herein may be scaled in size, modified, or adapted to be suitably implanted into the body and configured to support or provide cardiac based therapy based on the adjustable and controllable characteristics of the compression device used alone to directly contact internal structures as in the gastric compression embodiments or in conjunction with a cardiac support structure. As a result, compression devices described herein may be configured to provide adjustable cardiac support or adjust the tension of a cardiac support structure. In one embodiment, the compression device used for cardiac therapy operates in an active mode to aid in heart function and cardiac output. In another embodiment, the compression device used for cardiac therapy operates in a passive or retraining mode to assist heart structure.
Non-Medical and/or Medical Applications
Compression Devices as a Pump
In still other alternative configurations, one or more or a combination of the compression devices or methods of operation of one or more compression devices described herein may be scaled in size, modified, or adapted to be suitably configured to provide sequential compression to provide controllable peristaltic flow of a fluid in a deformable tube. In one configuration, three compression devices are positioned along a suitable tubing that may be deformed under the forces generated by the compression devices. The compression devices are then operated in the desired sequence to more the fluid in the tube to mimic the sequential squeezing of fluid by the rollers in a peristaltic pump.
One or more compression devices may be adapted to fit on tubing in laboratory or industrial setting for use in a peristaltic pumping system.
Compression Devices within Footwear
In still other alternative configurations, one or more or a combination of the compression devices or methods of operation of one or more compression devices described herein may be scaled in size, modified, or adapted to be suitably configured to provide added functionality to footwear. In one aspect, one or more compression devices integrated into a footwear article is operated to augment venous flow, to apply compression to the vascular beds of the foot, or otherwise increase beneficial or desired fluid flow in the foot engaged with the compression device enhanced footwear. This compression may be either non-medical, as a massage or for securement for example, or for a medical use to treat venous ulcers or venous insufficiency as described herein.
When a feature or element is herein referred to as being “on” another feature or element, it can be directly on the other feature or element or intervening features and/or elements may also be present. In contrast, when a feature or element is referred to as being “directly on” another feature or element, there are no intervening features or elements present. It will also be understood that, when a feature or element is referred to as being “connected”, “attached” or “coupled” to another feature or element, it can be directly connected, attached or coupled to the other feature or element or intervening features or elements may be present. In contrast, when a feature or element is referred to as being “directly connected”, “directly attached” or “directly coupled” to another feature or element, there are no intervening features or elements present. Although described or shown with respect to one embodiment, the features and elements so described or shown can apply to other embodiments. It will also be appreciated by those of skill in the art that references to a structure or feature that is disposed “adjacent” another feature may have portions that overlap or underlie the adjacent feature.
Terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. For example, as used herein, the singular forms “a”, “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms “comprises” and/or “comprising,” when used in this specification, specify the presence of stated features, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, steps, operations, elements, components, and/or groups thereof. As used herein, the term “and/or” includes any and all combinations of one or more of the associated listed items and may be abbreviated as “/”.
Spatially relative terms, such as “under”, “below”, “lower”, “over”, “upper” and the like, may be used herein for ease of description to describe one element or feature's relationship to another element(s) or feature(s) as illustrated in the figures. It will be understood that the spatially relative terms are intended to encompass different orientations of the device in use or operation in addition to the orientation depicted in the figures. For example, if a device in the figures is inverted, elements described as “under” or “beneath” other elements or features would then be oriented “over” the other elements or features. Thus, the exemplary term “under” can encompass both an orientation of over and under. The device may be otherwise oriented (rotated 90 degrees or at other orientations) and the spatially relative descriptors used herein interpreted accordingly. Similarly, the terms “upwardly”, “downwardly”, “vertical”, “horizontal” and the like are used herein for the purpose of explanation only unless specifically indicated otherwise.
Although the terms “first” and “second” may be used herein to describe various features/elements (including steps), these features/elements should not be limited by these terms, unless the context indicates otherwise. These terms may be used to distinguish one feature/element from another feature/element. Thus, a first feature/element discussed below could be termed a second feature/element, and similarly, a second feature/element discussed below could be termed a first feature/element without departing from the teachings of the present invention.
Throughout this specification and the claims which follow, unless the context requires otherwise, the word “comprise”, and variations such as “comprises” and “comprising” means various components can be co-jointly employed in the methods and articles (e.g., compositions and apparatuses including device and methods). For example, the term “comprising” will be understood to imply the inclusion of any stated elements or steps but not the exclusion of any other elements or steps.
As used herein in the specification and claims, including as used in the examples and unless otherwise expressly specified, all numbers may be read as if prefaced by the word “about” or “approximately,” even if the term does not expressly appear. The phrase “about” or “approximately” may be used when describing magnitude and/or position to indicate that the value and/or position described is within a reasonable expected range of values and/or positions. For example, a numeric value may have a value that is +/−0.1% of the stated value (or range of values), +/−1% of the stated value (or range of values), +/−2% of the stated value (or range of values), +/−5% of the stated value (or range of values), +/−10% of the stated value (or range of values), etc. Any numerical values given herein should also be understood to include about or approximately that value, unless the context indicates otherwise. For example, if the value “10” is disclosed, then “about 10” is also disclosed. Any numerical range recited herein is intended to include all sub-ranges subsumed therein. It is also understood that when a value is disclosed that “less than or equal to” the value, “greater than or equal to the value” and possible ranges between values are also disclosed, as appropriately understood by the skilled artisan. For example, if the value “X” is disclosed the “less than or equal to X” as well as “greater than or equal to X” (e.g., where X is a numerical value) is also disclosed. It is also understood that the throughout the application, data is provided in a number of different formats, and that this data, represents endpoints and starting points, and ranges for any combination of the data points. For example, if a particular data point “10” and a particular data point “15” are disclosed, it is understood that greater than, greater than or equal to, less than, less than or equal to, and equal to 10 and 15 are considered disclosed as well as between 10 and 15. It is also understood that each unit between two particular units are also disclosed. For example, if 10 and 15 are disclosed, then 11, 12, 13, and 14 are also disclosed.
Although various illustrative embodiments are described above, any of a number of changes may be made to various embodiments without departing from the scope of the invention as described by the claims. For example, the order in which various described method steps are performed may often be changed in alternative embodiments, and in other alternative embodiments one or more method steps may be skipped altogether. Optional features of various device and system embodiments may be included in some embodiments and not in others. Therefore, the foregoing description is provided primarily for exemplary purposes and should not be interpreted to limit the scope of the invention as it is set forth in the claims.
The examples and illustrations included herein show, by way of illustration and not of limitation, specific embodiments in which the subject matter may be practiced. As mentioned, other embodiments may be utilized and derived there from, such that structural and logical substitutions and changes may be made without departing from the scope of this disclosure. Such embodiments of the inventive subject matter may be referred to herein individually or collectively by the term “invention” merely for convenience and without intending to voluntarily limit the scope of this application to any single invention or inventive concept, if more than one is, in fact, disclosed. Thus, although specific embodiments have been illustrated and described herein, any arrangement calculated to achieve the same purpose may be substituted for the specific embodiments shown. This disclosure is intended to cover any and all adaptations or variations of various embodiments. Combinations of the above embodiments, and other embodiments not specifically described herein, will be apparent to those of skill in the art upon reviewing the above description.
This application claims priority to U.S. Provisional Application No. 62/328,574 filed Apr. 27, 2016 and titled “ADAPTIVE COMPRESSION THERAPY SYSTEM”, which is herein incorporated by reference in its entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 718766 | Ingram | Jan 1903 | A |
| 2118699 | Chappell | May 1938 | A |
| 2486667 | Meister | Nov 1949 | A |
| 2528843 | Poor | Nov 1950 | A |
| 2781041 | Weinberg | Feb 1957 | A |
| 3094116 | Logan et al. | Jun 1963 | A |
| 3683897 | Shield et al. | Aug 1972 | A |
| 3804084 | Lehman | Apr 1974 | A |
| 3853121 | Mizrachy et al. | Dec 1974 | A |
| 3859989 | Spielberg | Jan 1975 | A |
| 3862629 | Rotta | Jan 1975 | A |
| 3935984 | Lichowsky | Feb 1976 | A |
| 3942518 | Tenteris et al. | Mar 1976 | A |
| 3993053 | Grossan | Nov 1976 | A |
| 4004579 | Dedo | Jan 1977 | A |
| 4029087 | Dye et al. | Jun 1977 | A |
| 4054129 | Byars et al. | Oct 1977 | A |
| 4079962 | Frechin | Mar 1978 | A |
| 4206765 | Huber | Jun 1980 | A |
| 4207876 | Annis | Jun 1980 | A |
| 4243039 | Haifa | Jan 1981 | A |
| 4253449 | Arkans et al. | Mar 1981 | A |
| 4320746 | Arkans et al. | Mar 1982 | A |
| 4333181 | Corriero | Jun 1982 | A |
| 4375217 | Arkans | Mar 1983 | A |
| 4396010 | Arkans | Aug 1983 | A |
| 4402312 | Villari et al. | Sep 1983 | A |
| 4574789 | Forster | Mar 1986 | A |
| 4577622 | Jennings | Mar 1986 | A |
| 4583522 | Aronne | Apr 1986 | A |
| 4608740 | Bloys et al. | Sep 1986 | A |
| 4732140 | Stoffregen | Mar 1988 | A |
| 4738249 | Linman et al. | Apr 1988 | A |
| 4754560 | Nerrinck | Jul 1988 | A |
| 4770164 | Lach et al. | Sep 1988 | A |
| 4793328 | Kolstedt et al. | Dec 1988 | A |
| 4841956 | Gardner et al. | Jun 1989 | A |
| 4858596 | Kolstedt et al. | Aug 1989 | A |
| 4865020 | Bullard | Sep 1989 | A |
| 4928674 | Halperin et al. | May 1990 | A |
| 4966396 | Dye | Oct 1990 | A |
| 4982732 | Morris et al. | Jan 1991 | A |
| 5003711 | Nerrinck et al. | Apr 1991 | A |
| 5009222 | Her | Apr 1991 | A |
| 5022387 | Hasty | Jun 1991 | A |
| 5027797 | Bullard | Jul 1991 | A |
| 5052375 | Stark et al. | Oct 1991 | A |
| 5108393 | Ruffa | Apr 1992 | A |
| 5117812 | McWhorter | Jun 1992 | A |
| 5186163 | Dye | Feb 1993 | A |
| 5226874 | Heinz et al. | Jul 1993 | A |
| 5263473 | McWhorter | Nov 1993 | A |
| 5277697 | France et al. | Jan 1994 | A |
| 5334131 | Omandam et al. | Aug 1994 | A |
| 5346461 | Heinz | Sep 1994 | A |
| 5383894 | Dye | Jan 1995 | A |
| 5399153 | Caprio et al. | Mar 1995 | A |
| 5407418 | Szpur | Apr 1995 | A |
| 5437610 | Cariapa et al. | Aug 1995 | A |
| 5454831 | Mcewen | Oct 1995 | A |
| 5472413 | Detty | Dec 1995 | A |
| 5496262 | Johnson et al. | Mar 1996 | A |
| 5513658 | Goseki | May 1996 | A |
| 5569297 | Makower et al. | Oct 1996 | A |
| 5571075 | Bullard | Nov 1996 | A |
| 5575761 | Hajianpour | Nov 1996 | A |
| 5588954 | Riibando et al. | Dec 1996 | A |
| 5588955 | Johnson, Jr. et al. | Dec 1996 | A |
| 5591200 | Cone et al. | Jan 1997 | A |
| 5626556 | Tobler et al. | May 1997 | A |
| 5738637 | Kelly et al. | Apr 1998 | A |
| 5769801 | Tumey et al. | Jun 1998 | A |
| 5843007 | McEwen et al. | Dec 1998 | A |
| 5865776 | Springs | Feb 1999 | A |
| 5873848 | Fulkerson | Feb 1999 | A |
| 5951502 | Peeler et al. | Sep 1999 | A |
| 5997465 | Savage et al. | Dec 1999 | A |
| 6007459 | Burgess | Dec 1999 | A |
| 6010470 | Albery et al. | Jan 2000 | A |
| 6010471 | Ben-Noon | Jan 2000 | A |
| 6029294 | Saringer et al. | Feb 2000 | A |
| 6066106 | Sherman et al. | May 2000 | A |
| 6077218 | Alfemess | Jun 2000 | A |
| 6123662 | Alferness et al. | Sep 2000 | A |
| 6123681 | Brown | Sep 2000 | A |
| 6135116 | Vogel et al. | Oct 2000 | A |
| 6142962 | Mollenauer et al. | Nov 2000 | A |
| 6152893 | Pigg et al. | Nov 2000 | A |
| 6174295 | Cantrell et al. | Jan 2001 | B1 |
| 6231280 | Bullen | May 2001 | B1 |
| 6231532 | Watson et al. | May 2001 | B1 |
| 6269500 | Saringer | Aug 2001 | B1 |
| 6290662 | Morris et al. | Sep 2001 | B1 |
| 6334363 | Testud et al. | Jan 2002 | B1 |
| 6423017 | Brotz | Jul 2002 | B2 |
| 6436064 | Kloecker | Aug 2002 | B1 |
| 6440093 | McEwen et al. | Aug 2002 | B1 |
| 6450173 | Forsell | Sep 2002 | B1 |
| 6468237 | Lina | Oct 2002 | B1 |
| 6478757 | Barak | Nov 2002 | B1 |
| 6494852 | Barak et al. | Dec 2002 | B1 |
| 6537237 | Hopkins et al. | Mar 2003 | B1 |
| 6551280 | Knighton et al. | Apr 2003 | B1 |
| 6558338 | Wasserman | May 2003 | B1 |
| 6589194 | Calderon et al. | Jul 2003 | B1 |
| 6616620 | Sherman et al. | Sep 2003 | B2 |
| 6689076 | Saringer | Feb 2004 | B2 |
| 6780163 | Krusenklaus | Aug 2004 | B1 |
| 6806573 | Hu | Oct 2004 | B2 |
| 6827670 | Stark et al. | Dec 2004 | B1 |
| 6869408 | Sherman et al. | Mar 2005 | B2 |
| 6905456 | Brunner et al. | Jun 2005 | B1 |
| 6939314 | Hall et al. | Sep 2005 | B2 |
| 6945944 | Kuiper et al. | Sep 2005 | B2 |
| 6952614 | Choi | Oct 2005 | B2 |
| 6966884 | Waldridge et al. | Nov 2005 | B2 |
| 7004919 | Gaylord et al. | Feb 2006 | B2 |
| 7025738 | Hall | Apr 2006 | B2 |
| 7044924 | Roth et al. | May 2006 | B1 |
| 7127370 | Kelly et al. | Oct 2006 | B2 |
| 7135007 | Scott et al. | Nov 2006 | B2 |
| 7173161 | Kandt | Feb 2007 | B1 |
| 7252646 | Bolam et al. | Aug 2007 | B2 |
| 7270642 | Ouchene et al. | Sep 2007 | B2 |
| 7354410 | Perry et al. | Apr 2008 | B2 |
| 7534215 | Saringer | May 2009 | B2 |
| 7559906 | Bugo | Jul 2009 | B2 |
| 7559908 | Ravikumar | Jul 2009 | B2 |
| 7591796 | Barak et al. | Sep 2009 | B1 |
| 7618384 | Nardi et al. | Nov 2009 | B2 |
| 7637879 | Barak et al. | Dec 2009 | B2 |
| 7637922 | Johnson et al. | Dec 2009 | B2 |
| D610263 | Dagan et al. | Feb 2010 | S |
| 7819829 | Chandran | Oct 2010 | B1 |
| 7823219 | Freund | Nov 2010 | B2 |
| 7850629 | Ravikumar | Dec 2010 | B2 |
| 7857777 | Larson et al. | Dec 2010 | B2 |
| 7862525 | Carkner et al. | Jan 2011 | B2 |
| 7905849 | Park | Mar 2011 | B2 |
| 7976486 | Raley et al. | Jul 2011 | B2 |
| 7981066 | Lewis | Jul 2011 | B2 |
| 8029450 | Brown et al. | Oct 2011 | B2 |
| 8092367 | Raman et al. | Jan 2012 | B2 |
| 8162869 | Graham | Apr 2012 | B2 |
| 8175713 | Cywinski | May 2012 | B1 |
| 8177734 | Vess | May 2012 | B2 |
| 8192380 | Nardi | Jun 2012 | B2 |
| 8235921 | Rousso et al. | Aug 2012 | B2 |
| 8235923 | Avitable et al. | Aug 2012 | B2 |
| 8241233 | Litton et al. | Aug 2012 | B2 |
| 8257289 | Vess | Sep 2012 | B2 |
| 8313450 | Ben-Nun | Nov 2012 | B2 |
| 8382693 | Guldalian | Feb 2013 | B1 |
| 8388557 | Moomiaie-Qajar et al. | Mar 2013 | B2 |
| 8394042 | Mirza | Mar 2013 | B1 |
| 8403870 | Vess | Mar 2013 | B2 |
| 8419665 | Cook | Apr 2013 | B2 |
| 8419666 | Liu et al. | Apr 2013 | B2 |
| 8444582 | Gobet | May 2013 | B2 |
| 8449483 | Eddy | May 2013 | B2 |
| 8523794 | Iker et al. | Sep 2013 | B2 |
| 8527043 | Dupelle et al. | Sep 2013 | B2 |
| 8578939 | Kimani Mwangi et al. | Nov 2013 | B1 |
| 8597194 | Barak | Dec 2013 | B2 |
| 8597214 | Von Holgreen | Dec 2013 | B2 |
| 8636679 | Linnane et al. | Jan 2014 | B2 |
| 8721575 | Brown et al. | May 2014 | B2 |
| 8728016 | Reeves et al. | May 2014 | B2 |
| 8740828 | Brown et al. | Jun 2014 | B2 |
| 8753299 | Waldon, Sr. | Jun 2014 | B1 |
| 8753300 | Deshpande | Jun 2014 | B2 |
| 8764690 | Gough | Jul 2014 | B2 |
| 8779230 | Murphy et al. | Jul 2014 | B2 |
| 8795209 | Herken et al. | Aug 2014 | B2 |
| 8801643 | Deshpande et al. | Aug 2014 | B2 |
| 8845562 | Receveur et al. | Sep 2014 | B2 |
| 8858473 | Olson et al. | Oct 2014 | B2 |
| 8858474 | Olson et al. | Oct 2014 | B2 |
| 8858475 | Olson et al. | Oct 2014 | B2 |
| 8864691 | Olson et al. | Oct 2014 | B2 |
| 8900168 | Yamashiro et al. | Dec 2014 | B2 |
| 8942800 | Thiagrajan et al. | Jan 2015 | B2 |
| 8992449 | Mansfield et al. | Mar 2015 | B2 |
| 9032551 | Hildebrandt | May 2015 | B2 |
| 9033906 | Nolan et al. | May 2015 | B2 |
| 9050202 | Bache | Jun 2015 | B2 |
| 9084713 | Brown et al. | Jul 2015 | B2 |
| 9114054 | Bennett | Aug 2015 | B2 |
| 9119760 | Purdy et al. | Sep 2015 | B2 |
| 9161878 | Pamplin et al. | Oct 2015 | B1 |
| 9168195 | Sankai | Oct 2015 | B2 |
| 9168197 | Malhi et al. | Oct 2015 | B2 |
| 9204799 | Davies et al. | Dec 2015 | B2 |
| 9205021 | Malhi | Dec 2015 | B2 |
| 9211225 | Farrow et al. | Dec 2015 | B2 |
| 9211226 | Menzel | Dec 2015 | B1 |
| 9216122 | Dzioba et al. | Dec 2015 | B2 |
| 9248074 | Toth | Feb 2016 | B2 |
| 9265693 | Sudarev et al. | Feb 2016 | B2 |
| 9271890 | Pamplin et al. | Mar 2016 | B1 |
| 9283135 | Farrow | Mar 2016 | B2 |
| 9295605 | Yurko et al. | Mar 2016 | B2 |
| 9326911 | Wyatt et al. | May 2016 | B2 |
| 9421142 | Malhi et al. | Aug 2016 | B2 |
| 9433532 | Vess | Sep 2016 | B2 |
| 9433537 | Zelka | Sep 2016 | B2 |
| 9433711 | Pratt et al. | Sep 2016 | B2 |
| 9439828 | Mayer et al. | Sep 2016 | B2 |
| 9522096 | Jensen et al. | Dec 2016 | B2 |
| 9539166 | Wild et al. | Jan 2017 | B2 |
| 9539173 | Jeppsson | Jan 2017 | B2 |
| 9549867 | El-Messeiry et al. | Jan 2017 | B1 |
| 9572720 | Hanlon et al. | Feb 2017 | B2 |
| 9872790 | Capra | Jan 2018 | B2 |
| 20020026131 | Halperin | Feb 2002 | A1 |
| 20020052568 | Houser | May 2002 | A1 |
| 20020169399 | Rastegar et al. | Nov 2002 | A1 |
| 20040073146 | Weintraub et al. | Apr 2004 | A1 |
| 20050027218 | Filtvedt et al. | Feb 2005 | A1 |
| 20050043657 | Couvillon | Feb 2005 | A1 |
| 20050101887 | Stark et al. | May 2005 | A1 |
| 20050107725 | Wild et al. | May 2005 | A1 |
| 20050267387 | Baldauf et al. | Dec 2005 | A1 |
| 20050273025 | Houser | Dec 2005 | A1 |
| 20060047232 | Bourne et al. | Mar 2006 | A1 |
| 20060058715 | Hui et al. | Mar 2006 | A1 |
| 20060074362 | Rousso | Apr 2006 | A1 |
| 20060079824 | Munch-Fats et al. | Apr 2006 | A1 |
| 20060083623 | Higgins | Apr 2006 | A1 |
| 20060122546 | Rousso | Jun 2006 | A1 |
| 20060135894 | Linnane et al. | Jun 2006 | A1 |
| 20060173238 | Starkebaum | Aug 2006 | A1 |
| 20070038167 | Tabron et al. | Feb 2007 | A1 |
| 20070049852 | Linnane et al. | Mar 2007 | A1 |
| 20070049853 | Bonnefin et al. | Mar 2007 | A1 |
| 20070055188 | Avni | Mar 2007 | A1 |
| 20070173886 | Rousso et al. | Jul 2007 | A1 |
| 20070249976 | Tucker et al. | Oct 2007 | A1 |
| 20070249977 | Bonnefin et al. | Oct 2007 | A1 |
| 20080004548 | Oshmyansky | Jan 2008 | A1 |
| 20080015630 | Rousso | Jan 2008 | A1 |
| 20080039752 | Rousso | Feb 2008 | A1 |
| 20080059239 | Gerst et al. | Mar 2008 | A1 |
| 20080066272 | Hammerslag | Mar 2008 | A1 |
| 20080071204 | Linnane | Mar 2008 | A1 |
| 20080097268 | Rousso | Apr 2008 | A1 |
| 20080146980 | Rousso et al. | Jun 2008 | A1 |
| 20080243041 | Brenner et al. | Oct 2008 | A1 |
| 20080255481 | Quintana et al. | Oct 2008 | A1 |
| 20080255494 | Rousso et al. | Oct 2008 | A1 |
| 20080262399 | Kovelman | Oct 2008 | A1 |
| 20080269543 | Rousso | Oct 2008 | A1 |
| 20080319359 | Moomiaie-Qajar | Dec 2008 | A1 |
| 20090082707 | Rumsey | Mar 2009 | A1 |
| 20090287109 | Ferren et al. | Nov 2009 | A1 |
| 20090299242 | Hasegawa | Dec 2009 | A1 |
| 20100056966 | Toth | Mar 2010 | A1 |
| 20100139057 | Soderberg | Jun 2010 | A1 |
| 20100217167 | Ingimundarson | Aug 2010 | A1 |
| 20110015498 | Mestrovic et al. | Jan 2011 | A1 |
| 20110066093 | Vess | Mar 2011 | A1 |
| 20110196189 | Milbocker | Aug 2011 | A1 |
| 20110319787 | Lamoise | Dec 2011 | A1 |
| 20120004587 | Nickel | Jan 2012 | A1 |
| 20120010547 | Hinds | Jan 2012 | A1 |
| 20120029404 | Weaver, II | Feb 2012 | A1 |
| 20120065561 | Ballas | Mar 2012 | A1 |
| 20120083712 | Watson et al. | Apr 2012 | A1 |
| 20120253252 | Weaver, II | Oct 2012 | A1 |
| 20130085430 | Deshpande et al. | Apr 2013 | A1 |
| 20130204106 | Bennett | Aug 2013 | A1 |
| 20130237889 | Wright et al. | Sep 2013 | A1 |
| 20130237891 | Fryman | Sep 2013 | A1 |
| 20130345612 | Bannister | Dec 2013 | A1 |
| 20140082963 | Beers | Mar 2014 | A1 |
| 20140094725 | Malhi et al. | Apr 2014 | A1 |
| 20140257156 | Capra | Sep 2014 | A1 |
| 20140276308 | DiAngelo et al. | Sep 2014 | A1 |
| 20140303536 | Guldalian | Oct 2014 | A1 |
| 20150065930 | Wyatt et al. | Mar 2015 | A1 |
| 20150150705 | Capra | Jun 2015 | A1 |
| 20150297132 | Bichel et al. | Oct 2015 | A1 |
| 20150297437 | Neuenhahn et al. | Oct 2015 | A1 |
| 20150359700 | Davis et al. | Dec 2015 | A1 |
| 20150374573 | Horst et al. | Dec 2015 | A1 |
| 20160022528 | Wyatt | Jan 2016 | A1 |
| 20160100793 | Barak | Apr 2016 | A1 |
| 20160310310 | White | Oct 2016 | A1 |
| 20160374886 | Wyatt et al. | Dec 2016 | A1 |
| Number | Date | Country |
|---|---|---|
| 19505765 | Oct 1995 | DE |
| 20213196 | Jan 2004 | DE |
| 2443208 | Apr 2008 | GB |
| 1020070027506 | Mar 2007 | KR |
| WO1997004820 | Feb 1997 | WO |
| WO2000028334 | May 2000 | WO |
| WO2001032124 | May 2001 | WO |
| WO2006103422 | Oct 2006 | WO |
| WO2007033401 | Mar 2007 | WO |
| WO2008003920 | Jan 2008 | WO |
| WO2009104127 | Aug 2009 | WO |
| WO2010085111 | Jul 2010 | WO |
| WO2017027145 | Feb 2017 | WO |
| Entry |
|---|
| Mosti et al.; “Comparison between a new, two-component compression system with zinc paste bandages for leg ulcer healing: a prospective, multicenter, randomized, controlled trial monitoring sub-bandage pressures”; Wounds; vol. 23(5); pp. 126-134; May 2011. |
| Partsch; “The static stiffness index: a simple method to assess the elastic property of compression material in vivo”; Dermatologic Surgery; vol. 31(6); pp. 625-630; Jun. 2005. |
| Partsch et al.; “Measurement of lower leg compression in vivo: recommendations for the performance of measurements of interface pressure and stiffness”; Dermatologic Surgery; vol. 32(2); pp. 224-233; Feb. 2006. |
| Partsch et al.; “Interface pressure and stiffness of ready made compression stockings: Comparison of in vivo and in vitro measurements”; Journal of Vascular Surgery; vol. 44(4); pp. 809-814; Oct. 2006. |
| Allan et al; “The use of graduated compression stockings in the prevention of postoperative deep vein thrombosis”; Br. J. Surg.; vol. 70(3); pp. 172-174; Mar. 1983. |
| Badr et al.; “Differences in local environment determine the site of physiological angiogenesis in rat skeletal muscle”; Experimental Physiology; vol. 88(5); pp. 565-568; Sep. 2003. |
| Butson; “Intermittent pneumatic calf compression for prevention of deep venous thrombosis in general abdominal surgery”; Am J Surg; vol. 142(4); pp. 525-527; Oct. 1981. |
| Byl et al.; “Low-dose ultrasound effects on wound healing: a controlled study with Yucatan pigs”; Arch Phys Med Rehabil.; vol. 73(7); pp. 656-664; Jul. 1992. |
| Clagett et al.; “Prevention of venous thromboembolism in general surgical patients”; Ann Surg; vol. 208(2); pp. 227-240; Aug. 1988. |
| Comerota et al.; “The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis”; Ann Surg; vol. 226(3); pp. 306-314; Sep. 1997. |
| Dawson et al.; “A comparison of the microcirculation in rat fast glycolytic and slow oxidative muscles at rest and during contractions”; Microvascular Research; vol. 33(2); pp. 167-182; Mar. 1987. |
| Deveci et al.; “Relationship between capillary angiogenesis, fiber type, and fiber size in chronic systemic hypoxia”; Am. J. Heart Circ. Physiol; vol. 281(1); pp. H241-H585; Jul. 2001. |
| Dyson et al.; “Induction of mast cell degranulation in skin by ultrasound”; IEEE Transactions on Ultrasonics, Fenoelectrics, and Frequency Control; vol. 33(2); pp. 194-201; Feb. 1986. |
| Dyson et al.; “Stimulation of tissue repair by ultrasound: a survey of the mechanisms involved”; Physiotherapy; vol. 64(4); pp. 105-108; Apr. 1978. |
| Egginton et al.; “Capillary growth in relation to blood flow and performance in overloaded rat skeletal muscle”; J. Appl. Physiol; vol. 85(6); pp. 2025-2032; Dec. 1998. |
| Heit; “Venous thromboembolism epidemiology: implications for prevention and management”; Seminars in Thrombosis and Hemostasis; vol. 28, Supp 2; pp. 3-13; Jun. 2002. |
| Hills et al.; “Prevention of deep vein thrombosis by intermittent pneumatic compression of calf”; British Medical Journal; vol. 1(5793); pp. 131-135; Jan. 1972. |
| Hudicka et al.; “Is physiological angiogenesis in skeletal muscle regulated by changes in microcirculation?”; Microcirculation; vol. 5(1); pp. 5, 7-23; Feb. 1998. |
| Hudicka et al.; “Early changes in fiber profile and capillary density in long-term stimulated muscles”; Am J Physiol; vol. 243(4); pp. H528-H535; Oct. 1982. |
| Milkiewicz et al.; “Association between shear stress, angiogenesis, and VEGF in skeletal muscles in vivo”; Microcirculation; vol. 8(4); pp. 229-241; Aug. 2001. |
| Husmann; “The treatment of peripheral arterial disease with mechanical compression and angioplasty with focus on vascular dysfunction”; https://www.researchgate.net/publication/281726960; pp. 1-6; Jan. 2010. |
| Delis et al.; “Effects of intermittent pneumatic compression of the calf and thigh on arterial calf inflow: a study of normals, claudicants, and grafted arteriopaths”; Surgery; vol. 129(2); pp. 188-195; Feb. 2001. |
| Delis et al.; “Haemodynamic effect of intermittent pneumatic compression of the leg after infrainguinal arterial bypass grafting”; British Journal of Surgery; vol. 91(4); (Manuscript copy, 9 pages); Apr. 2004. |
| Husmann et al.; “Integrity of venoarteriolar reflex determines level of microvascular skin flow enhancement with intermittent pneumatic compression”; Journal of Vascular Surgery; vol. 48(6); pp. 1509-1513; Dec. 2008. |
| Husmann et al.; “Long-term effects of endovascular angioplasty on orthostatic vasocutaneous autoregulation in patients with peripheral atherosclerosis”; Journal of Vascular Surgery; vol. 44(5); pp. 993-997; Nov. 2006. |
| Husmann et al.; “Successful lower extremity angioplasty improves brachial artery flow-mediated dilation in patients with peripheral arterial disease”; Journal for Vascular Surgery; vol. 48(5); pp. 1211-1216; Nov. 2008. |
| Redolfi et al.; “Attenuation of obstructive sleep apnea by compression stockings in subjects with venous insufficiency”; Am J Respir Crit Care Med; vol. 184(9); pp. 1062-1066; Nov. 2011. |
| Johnson et al.; U.S. Appl. No. 15/499,850 entitled “Adaptive compression therapy systems and methods” filed Apr. 27, 2017. |
| Number | Date | Country | |
|---|---|---|---|
| 20170312161 A1 | Nov 2017 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62328574 | Apr 2016 | US |
